会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione
inhibitors of acyl-coa:cholesterol-acyl transferase
    • 酰基辅酶N,N',N'-三取代-5-二氨基亚甲基-1,3-二恶烷-4,6-二酮抑制剂:胆固醇 - 酰基转移酶
    • US5380853A
    • 1995-01-10
    • US152656
    • 1993-11-15
    • William F. FobareDonald P. Strike
    • William F. FobareDonald P. Strike
    • C07D319/06C07D405/12C07F7/18C07D401/12
    • C07D319/06C07D405/12C07F7/1852
    • The compounds of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, quinolinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino or athaae analogous hetercyclic groups with from one to tahree substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基,烷氧基或苯基烷氧基。 R 1是具有1至多个取代基的选自卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,噻唑基,噻唑基,噻唑基,吡啶基,喹啉基,嘧啶基,吡嗪基,苯并咪唑基,苯基烷基哌啶基或吗啉代或类似的杂环基团。 1至6个碳原子的烷基氨基,每个烷基具有1至6个碳原子的二烷基氨基,1至6个碳原子的烷基或1至6个碳原子的烷氧基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,其中所述取代基是烷基,烷氧基,卤素,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 及其药学上可接受的盐; 是ACAT抑制剂,其中一些具有抗氧化性质。
    • 6. 发明授权
    • N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione
inhibitors of acyl-CoA:cholesterol-acyl transferase
    • 酰基辅酶A的N,N',N'-三取代-5-二氨基亚甲基-1,3-二恶烷-4,6-二酮抑制剂:胆固醇 - 酰基转移酶
    • US5399697A
    • 1995-03-21
    • US152613
    • 1993-11-15
    • William F. FobareDonald P. Strike
    • William F. FobareDonald P. Strike
    • C07D319/06C07D405/12C07F7/18C07D215/38C07D215/40
    • C07D319/06C07D405/12C07F7/1852
    • The compounds of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, quinolinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino or athaae analogous hetercyclic groups with from one to three substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基,烷氧基或苯基烷氧基。 R 1是具有1至3个选自卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,苯基,噻唑基,噻唑基,噻唑基,吡啶基,喹啉基,嘧啶基,吡嗪基,苯并咪唑基,苯基烷基哌啶基或吗啉代或类似的杂环基, 1至6个碳原子的烷基氨基,每个烷基具有1至6个碳原子的二烷基氨基,1至6个碳原子的烷基或1至6个碳原子的烷氧基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,其中所述取代基是烷基,烷氧基,卤素,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 及其药学上可接受的盐; 是ACAT抑制剂,其中一些具有抗氧化性质。
    • 7. 发明授权
    • N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione
inhibitors of acyl-CoA: cholesterol-acyl transferase
    • 酰基辅酶A的N,N',N'-三取代-5-二氨基亚甲基-1,3-二恶烷-4,6-二酮抑制剂:胆固醇 - 酰基转移酶
    • US5281714A
    • 1994-01-25
    • US998213
    • 1992-12-30
    • William F. FobareDonald P. Strike
    • William F. FobareDonald P. Strike
    • C07D319/06C07D405/12C07F7/18
    • C07D319/06C07D405/12C07F7/1852
    • The compounds of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, quinolinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino or athaae analogous hetercyclic groups with from one to tahree substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基,烷氧基或苯基烷氧基。 R 1是具有1至多个取代基的选自卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,噻唑基,噻唑基,噻唑基,吡啶基,喹啉基,嘧啶基,吡嗪基,苯并咪唑基,苯基烷基哌啶基或吗啉代或类似的杂环基团。 1至6个碳原子的烷基氨基,每个烷基具有1至6个碳原子的二烷基氨基,1至6个碳原子的烷基或1至6个碳原子的烷氧基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,其中所述取代基是烷基,烷氧基,卤素,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 及其药学上可接受的盐; 是ACAT抑制剂,其中一些具有抗氧化性质。
    • 10. 发明授权
    • N,N',N'-trisubstituted-bis-amino-3-methylene-2,4(3H,5H)-furandione
inhibitors of acyl-CoA:cholesterol-acyl transferase
    • N,N',N'-三取代 - 双 - 氨基-3-亚甲基-2,4(3H,5H) - 呋喃二酮的酰基辅酶A:胆固醇 - 酰基转移酶
    • US5153218A
    • 1992-10-06
    • US784202
    • 1991-10-28
    • William F. Fobare
    • William F. Fobare
    • C07D307/34
    • C07D307/34
    • The compound of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl or alkoxy; R.sub.1 is alkyl, hydroxyalkyl, alkenyl, cycloalkyl, phenyl, benzyl, phenylethyl or substituted phenyl, benzyl or phenylethyl, alkoxy, halogen, cyano, trifluoromethyl, amino, alkylamino, dialkylamino, nitro, phenyl, benzyl or phenethyl or R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, pyrimidinyl, pyrazinyl or benzamidazolyl; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl, alkoxy, hologen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; or a pharmaceutically acceptable salt thereof, are useful as ACAT inhibitors.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基或烷氧基; 卤素,氰基,三氟甲基,氨基,烷基氨基,二烷基氨基,硝基,苯基,苄基或苯乙基,或者R 1是噻吩基,咪唑基 ,噻唑基,吡啶基,嘧啶基,吡嗪基或苯并咪唑基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,烷氧基,氢原子,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 或其药学上可接受的盐可用作ACAT抑制剂。